Are generic medications safe and effective?

Journal of Psychosocial Nursing and Mental Health Services

Volumn 48, Issue 3, 2010, Pages 13-16

  Howland, Robert H ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; GENERIC DRUG; NEUROLEPTIC AGENT;

ARTICLE; ATTITUDE TO HEALTH; DRUG MONITORING; FOOD AND DRUG ADMINISTRATION; HUMAN; METHODOLOGY; PATIENT SELECTION; PSYCHIATRIC NURSING; PSYCHOLOGICAL THEORY; RANDOMIZED CONTROLLED TRIAL; SAFETY; TREATMENT OUTCOME; UNITED STATES;

ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; ATTITUDE TO HEALTH; DRUG MONITORING; DRUGS, GENERIC; HUMANS; PATIENT SELECTION; PSYCHIATRIC NURSING; PSYCHOLOGICAL THEORY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SAFETY; TREATMENT OUTCOME; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 77950876739     PISSN: 02793695     EISSN: None     Source Type: Journal    
DOI: 10.3928/02793695-20100204-01     Document Type: Article

References (17)

1. American Academy of Neurology. (2006). Position statement on the coverage of anticonvulsant drugs for the treatment of epilepsy. Retrieved from http://www.aan.com/globals/axon/assets/2323.pdf
2. Barsky, A.J., Saintfort, R., Rogers, M.P., & Borus, J.F. (2002). Nonspecific medication side effects and the nocebo phenomenon. Journal of the American Medical Association, 287, 622-627.
3. Borgherini, G. (2003). The bioequivalence and therapeutic efficacy of generic versus brand-name psychoactive drugs. Clinical Therapeutics, 25, 1578-1592.
4. Brody, H.B., & Brody, D. (2000). Three perspectives on the placebo response: Expectancy, conditioning, and meaning. Advances in Mind-Body Medicine, 16, 216-232.
5. Chenu, F., Batten, L.A., Zernig, G., Ladstaetter, E., Hebert, C., & Blier, P. (2009). Comparison of pharmacokinetic profiles of brand-name and generic formulations of citalopram and venlafaxine: A crossover study. Journal of Clinical Psychiatry, 70, 958-966.
6. Devine, S.T., Weisbart, E., Barron, J., & Behm, A. (2010). Acute epilepsy exacerbations in patients switched between A-rated anti-epileptic drugs. Current Medical Research and Opinion, 26, 455-463.
7. Generic drugs revisited. (2009). Medical Letter on Drugs and Therapeutics, 51(1323), 81-82.
8. Howland, R.H. (2009). What makes a generic medication generic? Journal of Psychosocial Nursing and Mental Health Services, 47(12), 17-20.
9. Howland, R.H. (2010a). Evaluating the bioavailability and bioequivalence of generic medications. Journal of Psychosocial Nursing and Mental Health Services, 48(1), 13-16.
10. Howland, R.H. (2010b). When is a "generic" medication not really a generic? Confusion about medication products containing the same active ingrediingredient. Journal of Psychosocial Nursing and Mental Health Services, 48(2), 13-16.
11. Krell, H.V., Leuchter, A.F., Morgan, M., Cook, I.A., & Abrams, M. (2004). Subject expectations of treatment effectiveness and outcome of treatment with an experimental antidepressant. Journal of Clinical Psychiatry, 65, 1174-1179.
12. Oluboka, O., Stewart, S., Landry, S., & Adams, S. (2010). Does therapeutic equivalence follow bioequivalence? A randomized trial to assess clinical effects after switching from Clozaril to generic clozapine (Gen-Clozapine). Journal of Clinical Pharmacology. Advanced online publication. doi:10.1177/0091270009347871
13. Stewart-Williams, S., & Podd, J. (2004). The placebo effect: Dissolving the expectancy versus conditioning debate. Psychological Bulletin, 130, 324-340.
14. U.S. Food and Drug Administration. (2009). Review of therapeutic equivalence generic bupropion XL 300 mg and Wellbutrin XL 300 mg. Retrieved from http://www.fda.gov/AboutFDA/CentersOffices/CDER/ucm153270.htm
15. Vergouwen, A.C., & Bakker, A. (2002). [Adverse effects after switching to a different generic form of paroxetine: Paroxetine mesylate instead of paroxetine HCl hemihydrate.] Nederlands Tijdschrift voor Geneeskunde, 146, 811-812.
16. Waber, R.L., Shiv, B., Carmon, Z., & Ariely, D. (2008). Commercial features of placebo and therapeutic efficacy. Journal of the American Medical Association, 299, 1016-1017.
17. Wellbutrin versus generic bupropion. (2008). Medical Letter on Drugs and Therapeutics, 50(1290), 54-55.